Search
for
Sort by
Research 181–210 of 1000+
- Update to acne vulgaris treatment for Canadian practice
- A cross sectional study evaluating the relationship of acne to androgenetic alopecia subtype and severity
- The relationship between acne vulgaris and insulin resistance in adolescents
- Evaluation of Total Oxidant and Total Antioxidant Status in Patients with Acne Vulgaris
- An Unusual “Side Effect” of an Acne Drug
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- 11 Treatment of hirsutism and acne with cyproterone acetate
- The treatment of acne
- Acne and Systemic Diseases
- Acne tarda: paplitimas, endokrininis ryšys, terapinės priemonės.
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- Acne exacerbation after tofacitinib treatment for alopecia areata
- EFFECT OF METFORMIN THERAPY IN FEMALE VISITING DERMATOLOGIST FOR ACNE VULGARIS HAVING ENDOCRINE AND SONOGRAPHIC CHARACTERISTICS OF POLYCYSTIC OVARY SYNDROME (PCOS)
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Oral Contraception and the Treatment of Acne: Where are we?
- Treatment of acne with intermittent isotretinoin, cohort study
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis
- Erlotinib induced acneiform eruption: A case report
- A Case of Folliculitis Decalvans With Concomitant Acne Keloidalis Nuchae, Androgenic Alopecia, and Profound Postinflammatory Hyperpigmentation
- Female type of adult acne: Physiological and psychological considerations and management
- Sponsored Lecture 2 : Global aspects of acne treatment: current & future benefits
- Retinoids: best solutions for acne…
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Changes of sex hormone levels in male acne patients with normal serum testosterone and effect of antiandrogen therapy
- Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road Ahead
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata